Codes / ICD10CM / T48.295

T48.295 Adverse effect of other drugs acting on muscles

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of other drugs acting on muscles

Summary

This condition describes adverse effects resulting from exposure to drugs that act on muscles, where the specific agent is classified as "other" (not otherwise specified). It includes clinical outcomes from unintended or unexpected reactions to these medications, typically occurring during therapeutic use or accidental exposure.

Causes

Adverse effects may result from therapeutic administration of muscle-acting drugs, including incorrect dosing, drug interactions, or idiosyncratic reactions. Underlying mechanisms can involve pharmacologic effects, allergic responses, or metabolic disturbances related to the drug's action on muscle tissue.

Risk Factors

  • Use of medications with narrow therapeutic windows.
  • Concurrent use of multiple drugs with overlapping muscle effects.
  • Renal or hepatic impairment affecting drug metabolism.
  • History of prior adverse drug reactions.
  • Genetic predisposition to drug sensitivity.

Symptoms

  • Muscle weakness or spasms.
  • Respiratory distress or altered breathing patterns.
  • Dizziness, confusion, or cognitive changes.
  • Gastrointestinal symptoms (nausea, vomiting, diarrhea).
  • Cardiovascular instability (hypotension, arrhythmias).

Diagnosis

Clinical evaluation focuses on symptom correlation with medication history, including dosage, timing, and route of administration. Laboratory tests may assess drug levels, metabolic function, or organ involvement. Imaging or electromyography may be used to evaluate muscle or nerve function if indicated.

Treatment Options

Management involves discontinuing the offending drug, supportive care (e.g., respiratory support, fluid management), and specific antidotes if available. Symptomatic treatment addresses complications like pain, nausea, or cardiovascular instability. Monitoring for delayed reactions or organ damage is essential.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction, promptness of treatment, and underlying health status. Most adverse effects resolve with discontinuation of the drug and supportive care, but severe cases may require prolonged monitoring. Follow-up includes reassessment of symptoms and adjustment of future medication plans.

Complications

  • Respiratory failure requiring mechanical ventilation.
  • Prolonged muscle weakness or paralysis.
  • Cardiovascular collapse or arrhythmias.
  • Metabolic disturbances (e.g., electrolyte imbalances).
  • Long-term organ damage (e.g., renal or hepatic impairment).

Lifestyle & Prevention

  • Maintain accurate medication lists and share them with healthcare providers.
  • Follow dosing instructions carefully and avoid self-adjusting medications.
  • Store drugs securely to prevent accidental exposure.
  • Report any new or worsening symptoms to a healthcare provider promptly.
  • Discuss drug interactions with a pharmacist or provider before starting new medications.

When to Seek Professional Help

Seek immediate medical attention for severe symptoms like difficulty breathing, chest pain, severe dizziness, or loss of consciousness. Contact a provider for persistent or worsening symptoms, even if mild, to evaluate potential drug-related effects.

Tips for Medical Coders

Document the specific drug involved, administration details, and clinical manifestations to support coding. Ensure the adverse effect is directly linked to the drug's muscle-acting properties. Include any relevant lab results, treatment interventions, or follow-up notes to clarify the clinical context.

Book a walkthrough

T48.295 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.